| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MYLAN N V | 175,000 | 10,386,000 | 6.47% | ||
| 2 | WEST CORP | 300,000 | 10,119,000 | 6.30% | ||
| 3 | ARAMARK | 300,000 | 9,489,000 | 5.91% | ||
| 4 | ZENDESK INC | 350,000 | 7,942,000 | 4.94% | ||
| 5 | ENVISION HEALTHCARE HLDGS INC | 200,000 | 7,670,000 | 4.77% | ||
| 6 | SURGICAL CARE AFFILIATES INC COM | 150,000 | 5,150,000 | 3.21% | ||
| 7 | CATALENT INC | 150,000 | 4,673,000 | 2.91% | ||
| 8 | COMMSCOPE HLDG COMPANY INCORPORATED | 155,000 | 4,424,000 | 2.75% | ||
| 9 | MASTERCARD INCORPORATED | 50,000 | 4,320,000 | 2.69% | ||
| 10 | VALEANT PHARMACEUTICALS INTL | 20,000 | 3,972,000 | 2.47% | ||
| 11 | VOYA FINANCIAL INC | 90,000 | 3,880,000 | 2.42% | ||
| 12 | Marcus & Millichap Inc Com | 100,000 | 3,748,000 | 2.33% | ||
| 13 | CITIZENS FINL GROUP INC | 150,000 | 3,620,000 | 2.25% | ||
| 14 | BLOOMIN BRANDS INC | 146,800 | 3,572,000 | 2.22% | ||
| 15 | AVINGER INC | 300,016 | 3,327,000 | 2.07% | ||
| 16 | PINNACLE FOODS INC DEL | 75,000 | 3,061,000 | 1.91% | ||
| 17 | COHERUS BIOSCIENCES INC COM | 100,000 | 3,058,000 | 1.90% | ||
| 18 | BURLINGTON STORES INC | 50,000 | 2,971,000 | 1.85% | ||
| 19 | LA QUINTA HLDGS INC | 125,000 | 2,960,000 | 1.84% | ||
| 20 | TESARO INC | 50,000 | 2,870,000 | 1.79% | ||
| 21 | Q2 Holdings Inc | 135,000 | 2,854,000 | 1.78% | ||
| 22 | FORWARD PHARMA A/S | 100,000 | 2,832,000 | 1.76% | ||
| 23 | ZAYO GROUP HOLDINGS | 100,000 | 2,796,000 | 1.74% | ||
| 24 | CYBERARK SOFTWARE LTD SHS | 50,000 | 2,779,000 | 1.73% | ||
| 25 | BRIXMOR PROPERTY | 100,000 | 2,655,000 | 1.65% | ||
| 26 | ZS PHARMA INC | 60,000 | 2,525,000 | 1.57% | ||
| 27 | GRAY TELEVISION INC COM | 174,200 | 2,407,000 | 1.50% | ||
| 28 | SUMMIT MATLS INC CL A | 104,797 | 2,321,000 | 1.44% | ||
| 29 | FRANKLIN FINL NETWORK INC COM | 100,000 | 2,100,000 | 1.31% | ||
| 30 | NOVAVAX INC COM | 250,000 | 2,068,000 | 1.29% | ||
| 31 | METALDYNE PERFORMANCE GRO | 96,481 | 1,739,000 | 1.08% | ||
| 32 | Diplomat Pharmacy Inc | 50,000 | 1,729,000 | 1.08% | ||
| 33 | GOLDMAN SACHS BDC INC | 80,850 | 1,670,000 | 1.04% | ||
| 34 | HUBSPOT INCORPORATED | 40,000 | 1,596,000 | 0.99% | ||
| 35 | HEARTLAND EXPRESS INC COM | 65,600 | 1,559,000 | 0.97% | ||
| 36 | INTRA CELLULAR THERAPIES INC COM | 63,978 | 1,528,000 | 0.95% | ||
| 37 | Receptos Inc | 9,145 | 1,508,000 | 0.94% | ||
| 38 | INTERCEPT PHARMACEUTICAL | 5,000 | 1,410,000 | 0.88% | ||
| 39 | INSMED INC COM PAR .01 | 60,000 | 1,248,000 | 0.78% | ||
| 40 | RETROPHIN INC COM | 50,000 | 1,198,000 | 0.75% | ||
| 41 | SUCAMPO PHARMACEUTICALS INC | 75,000 | 1,167,000 | 0.73% | ||
| 42 | DIAMOND RESORTS INTL INC COM | 34,800 | 1,163,000 | 0.72% | ||
| 43 | FIRST REP BK SAN FRANCISCO C | 20,000 | 1,142,000 | 0.71% | ||
| 44 | Callidus Software Inc | 90,000 | 1,141,000 | 0.71% | ||
| 45 | EPIZYME INC COM | 59,100 | 1,110,000 | 0.69% | ||
| 46 | NATL PENN BANCSHARES INC | 100,000 | 1,077,000 | 0.67% | ||
| 47 | CONCERT PHARMACEUTICALS INC COM | 67,500 | 1,022,000 | 0.64% | ||
| 48 | Proteon Therapeutics | 82,902 | 964,000 | 0.60% | ||
| 49 | Tekmira Pharmaceuticals Corp. | 55,000 | 960,000 | 0.60% | ||
| 50 | TANDEM DIABETES CARE INC | 68,000 | 858,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-000946, filed 2015.04.20).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
